Gilead Sciences (GILD) Change in Acquisitions & Divestments (2009 - 2026)

Gilead Sciences (GILD) has 18 years of Change in Acquisitions & Divestments data on file, last reported at $36.0 million in Q1 2026.

• Quarterly Change in Acquisitions & Divestments changed N/A year-over-year to $36.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $890.0 million (up 145.92% YoY) and the FY2025 annual result came in at $854.0 million, up 161.16% from the prior year.
• Change in Acquisitions & Divestments retreated to $36.0 million in Q1 2026, from $822.0 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $2.3 billion in Q1 2024 to a low of -$1.9 billion in Q4 2024.
• A 5-year average of $236.9 million and a median of $161.5 million in 2022 frame the typical range for Change in Acquisitions & Divestments.
• The widest YoY moves for Change in Acquisitions & Divestments: up 599.07% in 2024, down 2077.55% in 2024.
• Tracing GILD's Change in Acquisitions & Divestments over 5 years: stood at $358.0 million in 2022, then slumped by 72.63% to $98.0 million in 2023, then slumped by 2077.55% to -$1.9 billion in 2024, then soared by 142.41% to $822.0 million in 2025, then tumbled by 95.62% to $36.0 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $36.0 million (Q1 2026), $822.0 million (Q4 2025), and $17.0 million (Q3 2025), per Business Quant data.